https://www.slideshare.net/GTAtherton/nac-patient-meeting-january-2014-1?ref=
| Date | Speaker | Title | Time starts | Duration |
| January 2014 | Graham Atherton | New antifungal drug class reported | 0’00’00secs | |
| Pippa Newton | What is Pseudomonas? | 0’31’15secs | ||
| Led by Graham Atherton | Entire meeting | 1’45’26secs |
Share this post
Latest News posts
🌿 New Antifungal Medicines on the Horizon: Olorofim and Fosmanogepix
November 11, 2025
When Scents Cause Symptoms: What Patients Say About Odour Triggers
November 10, 2025
Understanding Risk from Aspergillosis — and What’s Improving
November 10, 2025
Understanding Risk: How Common Is “Rare”?
November 10, 2025
Aspergillosis & Asthma: When Risks Peak Through the Year
November 10, 2025
🏗️ Damp, Dust and Indoor Air Quality
November 10, 2025
🫁 Understanding Chronic Cough in Aspergillosis
October 30, 2025
💼 Aspergillosis, Scent Sensitivity, and the Workplace
October 30, 2025
🩺 Article 1: Managing Side Effects of Aspergillosis Treatments
October 30, 2025
News archive
× Close
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
This content has been archived. It may no longer be relevant